Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetically engineered biological products in China. The company's main products include influenza virus split vaccine, quadrivalent influenza virus split vaccine, quadrivalent influenza virus split vaccine (pediatric formulation), H1N1 influenza A virus split vaccine, ACYW135 group meningococcal polysaccharide vaccine, recombinant hepatitis B vaccine (Hansenula polymorpha), group A and C meningococcal polysaccharide vaccine, freeze-dried human rabies vaccine (Vero cells), and adsorbed tetanus vaccine. It also offers products under development, such as freeze-dried Group A and Group C meningococcal conjugate vaccine, adsorbed cell-free tridiphtheria-tetanus combined vaccine, freeze-dried Haemophilus influenzae type b conjugate vaccine, and recombinant zoster vaccine (CHO cells), mRNA influenza vaccines, adsorbed tetanus vaccine, and novel adjuvanted influenza vaccines. In addition, it sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.
Frequently asked questions
What sector does Hualan Biological Bacterin Inc. (301207) operate in?
Hualan Biological Bacterin Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Hualan Biological Bacterin Inc. (301207) current stock price?
As of the latest data, Hualan Biological Bacterin Inc. stock price is CN¥18.15, with a previous close of CN¥17.92. Hualan Biological Bacterin Inc. gained CN¥0.23 in the last trading session, representing a 1.28% increase.
What is Hualan Biological Bacterin Inc. (301207) current market capitalization?
Hualan Biological Bacterin Inc. market cap is approximately 10.91 billion.
What is Hualan Biological Bacterin Inc. (301207) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.31, and the forward EPS is CN¥0.43.
What is Hualan Biological Bacterin Inc. (301207) Price-to-Earnings (P/E) ratio?
Hualan Biological Bacterin Inc. current P/E ratio is 58.55, with a forward P/E of 42.21.
Does Hualan Biological Bacterin Inc. (301207) pay dividends?
Yes. Hualan Biological Bacterin Inc. pays semiannual dividends with an annualized yield of 8.82% and an estimated annual payout of CN¥1.60 per share.
When is the next ex-dividend date for Hualan Biological Bacterin Inc. (301207)?
The next ex-dividend date is scheduled for December 15, 2026.
What is Hualan Biological Bacterin Inc. (301207) beta (volatility) score?
Hualan Biological Bacterin Inc. has a beta of 0.633, indicating lower volatility than the overall market.
